BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 33206944)

  • 21. Radiological characteristics of myelin oligodendrocyte glycoprotein antibody disease.
    Salama S; Khan M; Levy M; Izbudak I
    Mult Scler Relat Disord; 2019 Apr; 29():15-22. PubMed ID: 30658259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS.
    Duan Y; Zhuo Z; Li H; Tian DC; Li Y; Yang L; Gao C; Zhang T; Zhang X; Shi FD; Barkhof F; Liu Y
    J Neurol Neurosurg Psychiatry; 2021 Jul; 92(7):709-716. PubMed ID: 33687975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
    Jarius S; Kleiter I; Ruprecht K; Asgari N; Pitarokoili K; Borisow N; Hümmert MW; Trebst C; Pache F; Winkelmann A; Beume LA; Ringelstein M; Stich O; Aktas O; Korporal-Kuhnke M; Schwarz A; Lukas C; Haas J; Fechner K; Buttmann M; Bellmann-Strobl J; Zimmermann H; Brandt AU; Franciotta D; Schanda K; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Nov; 13(1):281. PubMed ID: 27802825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imaging Differences between Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis: A Multi-Institutional Study in Japan.
    Tatekawa H; Sakamoto S; Hori M; Kaichi Y; Kunimatsu A; Akazawa K; Miyasaka T; Oba H; Okubo T; Hasuo K; Yamada K; Taoka T; Doishita S; Shimono T; Miki Y
    AJNR Am J Neuroradiol; 2018 Jul; 39(7):1239-1247. PubMed ID: 29724765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spinal Cord Atrophy in Neuromyelitis Optica Spectrum Disorders Is Spatially Related to Cord Lesions and Disability.
    Cacciaguerra L; Valsasina P; Mesaros S; Martinelli V; Drulovic J; Filippi M; Rocca MA
    Radiology; 2020 Oct; 297(1):154-163. PubMed ID: 32720869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
    Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
    J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
    van Pelt ED; Wong YY; Ketelslegers IA; Hamann D; Hintzen RQ
    Eur J Neurol; 2016 Mar; 23(3):580-7. PubMed ID: 26593750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased radial diffusivity in spinal cord lesions in neuromyelitis optica compared with multiple sclerosis.
    Klawiter EC; Xu J; Naismith RT; Benzinger TL; Shimony JS; Lancia S; Snyder AZ; Trinkaus K; Song SK; Cross AH
    Mult Scler; 2012 Sep; 18(9):1259-68. PubMed ID: 22354742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain and cord imaging features in neuromyelitis optica spectrum disorders.
    Cacciaguerra L; Meani A; Mesaros S; Radaelli M; Palace J; Dujmovic-Basuroski I; Pagani E; Martinelli V; Matthews L; Drulovic J; Leite MI; Comi G; Filippi M; Rocca MA
    Ann Neurol; 2019 Mar; 85(3):371-384. PubMed ID: 30635936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
    Pröbstel AK; Rudolf G; Dornmair K; Collongues N; Chanson JB; Sanderson NS; Lindberg RL; Kappos L; de Seze J; Derfuss T
    J Neuroinflammation; 2015 Mar; 12():46. PubMed ID: 25889963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of recurrent myelitis associated with anti-myelin oligodendrocyte glycoprotein antibody that developed only as localized short spinal cord lesions].
    Matsumoto A; Kaneko K; Takahashi T; Nakashima I; Hisanaga K; Nagano I
    Rinsho Shinkeigaku; 2017 Nov; 57(11):729-732. PubMed ID: 29070750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
    Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
    Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Grading cervical cord damage in neuromyelitis optica and MS by diffusion tensor MRI.
    Benedetti B; Valsasina P; Judica E; Martinelli V; Ghezzi A; Capra R; Bergamaschi R; Comi G; Filippi M
    Neurology; 2006 Jul; 67(1):161-3. PubMed ID: 16832101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI differences between MOG antibody disease and AQP4 NMOSD.
    Salama S; Khan M; Shanechi A; Levy M; Izbudak I
    Mult Scler; 2020 Dec; 26(14):1854-1865. PubMed ID: 31937191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marked central canal T2-hyperintensity in MOGAD myelitis and comparison to NMOSD and MS.
    Webb LM; Cacciaguerra L; Krecke KN; Chen JJ; Sechi E; Redenbaugh V; Dubey D; Pittock SJ; Flanagan EP
    J Neurol Sci; 2023 Jul; 450():120687. PubMed ID: 37201267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myelitis in inflammatory disorders associated with myelin oligodendrocyte glycoprotein antibody and aquaporin-4 antibody: A comparative study in Chinese Han patients.
    ZhangBao J; Huang W; Zhou L; Wang L; Chang X; Lu C; Zhao C; Lu J; Quan C
    Eur J Neurol; 2021 Apr; 28(4):1308-1315. PubMed ID: 33220172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
    Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A
    Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole spinal transverse myelitis in neuromyelitis optica spectrum disorder.
    Etemadifar M; Mousavi S; Salari M; Hosseinian SA; Mansouri AR
    Mult Scler Relat Disord; 2024 Jul; 87():105666. PubMed ID: 38749352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.